TNB Tech Minute: Tesla Sales Surge Amid Broader EV Slump - WSJ Tech News Briefing

Summary3 min read

WSJ Tech News Briefing: TNB Tech Minute – Tesla Sales Surge Amid Broader EV Slump

Date: July 2, 2026
Host: Imani Moiz, The Wall Street Journal

Episode Overview

This Tech Minute delivers a rapid-fire roundup of pivotal tech industry news, with a central focus on Tesla’s strong Q2 sales performance set against a broader downturn in the American electric vehicle (EV) market. The update also spotlights a major funding round for the defense drone maker Quantum Systems and a new AI drug discovery partnership between Takeda and Insilico Medicine.

Key Discussion Points & Insights

1. Tesla’s Renewed Momentum in Electric Vehicle Sales

Tesla sold over 480,000 EVs globally in Q2
- Up nearly 25% year-over-year—a major resurgence for the automaker amid months of industry and brand headwinds.
- This quarter was the first to exclude new production of the luxury Model X and S, after production stopped in May. However, sales continued through the liquidation of remaining inventory.
- [00:20] Imani Moiz:
  “Tesla has regained momentum. The electric Automaker sold over 480,000 EVs globally in the second quarter, up nearly 25% from the same period last year.”
Broader US Electric Vehicle Market Slump
- In sharp contrast to Tesla’s growth, American EV sales fell by 25% in the first five months of 2026.
- Source: Data from Motor Intelligence.
- [00:53] Imani Moiz:
  “Tesla’s sales jump comes amid a wider downturn in the American EV market. Overall, electric sales in the US were down 25% for the first five months of the year.”

2. Quantum Systems’ $1.2 Billion Funding and Defense Tech Boom

German drone maker Quantum Systems doubled its valuation, reaching roughly $8 billion after raising $1.2 billion in new funding.
- Investment co-led by major players: Blackstone, Airbus, Advent (private equity), and Notius Partners (equity).
- Underscores booming investor appetite for defense technology.
- Quantum’s drones executed more than 19,000 missions in Ukraine last year—emphasizing growing operational relevance.
- The company is now focused on expanding drone manufacturing and increasing investments in AI-powered autonomous systems.
- [01:17] Imani Moiz:
  “Blackstone, Airbus, private equity firm Advent, and equity investor Notius Partners co-led the financing round, which highlights surging investor appetite for defense technology.”

3. Takeda and Insilico Medicine’s $6 Million AI Drug Discovery Partnership

Takeda, one of Japan’s pharmaceutical giants, announced a partnership with Boston-based biotech firm Insilico Medicine.
- The deal, valued at up to $6 million, grants Takeda rights to commercialize drugs found via Insilico’s proprietary AI platform.
- Insilico will spearhead drug discovery, while Takeda retains exclusive development and commercialization rights.
- Insilico receives $60 million upfront and is eligible for milestone payments and royalties.
- [01:47] Imani Moiz:
  “Takeda will pay the Boston-based biotech firm to use its proprietary platform to advance drug candidates across several therapeutic areas.”

Notable Quotes & Memorable Moments

On Tesla’s turnaround:
- “Tesla has regained momentum... sold over 480,000 EVs globally in the second quarter, up nearly 25% from the same period last year.”
  — Imani Moiz, [00:20]
On contrast in the EV marketplace:
- “Tesla’s sales jump comes amid a wider downturn in the American EV market. Overall, electric sales in the US were down 25% for the first five months of the year.”
  — Imani Moiz, [00:53]
On the quantum leap in defense tech investment:
- “Blackstone, Airbus, private equity firm Advent and equity investor Notius Partners co-led the financing round, which highlights surging investor appetite for defense technology.”
  — Imani Moiz, [01:17]

Important Segment Timestamps

| Timestamp | Segment Summary | |-----------|---------------------------------------------------------| | 00:20 | Tesla’s Q2 sales surge, Model X/S, and US EV downturn | | 01:10 | Quantum Systems’ funding and defense drone expansion | | 01:47 | Takeda & Insilico Medicine AI-powered drug partnership |

Tone and Delivery

The episode maintains a brisk, fact-driven pace, focusing on impactful business moves and tech trends, with a straightforward delivery reflecting The Wall Street Journal’s signature concise, informative style.

Takeaway:
This Tech Minute encapsulates the shifting dynamics of the EV market, the growing significance of defense tech, and the expanding reach of AI in drug discovery, offering listeners an incisive snapshot of tech’s evolving landscape as of July 2026.

Loading summary

Transcript5 lines

[00:01]
A
Hey, it's Ryan Knudson, host of the Journal Podcast, our show about money, business and power. If you're looking for more deeply reported stories like we share every day, consider becoming a subscriber to the Wall Street Journal. Visit subscribe.WSJ.com TheJournal all lowercase to subscribe now,
[00:20]
B
here's your afternoon TNB Tech minute for Thursday, July 2nd. I'm Imani Moiz for the Wall Street Journal. After months of slowing car sales and hits to its brand, Tesla has regained momentum. The electric Automaker sold over 480,000 EVs globally in the second quarter, up nearly 25% from the same period last year. The results mark the first time Tesla has reported vehicle sales since it stopped making the luxury Model X and Model S in May, though the company still sold its remaining inventory of those vehicles in the second quarter. Tesla's sales jump comes amid a wider downturn in the American EV market. Overall, electric sales in the US were down 25% for the first five months of the year. That's according to data from Motor Intelligence. German drone maker Quantum Systems has more than doubled its valuation with $1.2 billion in new funding, which values the company at roughly $8 billion. Blackstone, Airbus private equity firm Advent and equity investor Notius Partners co led the financing round, which highlights surging investor appetite for defense technology. Quantum said its systems completed over 19,000 missions in Ukraine last year. The startup says it's looking to expand drone manufacturing and boost investments in AI powered software for autonomous systems. And Japanese pharmaceutical giant Takeda has has formed an AI drug discovery partnership with Insilico Medicine in a deal potentially worth up to $6 million. Under the agreement announced today, Takeda will pay the Boston based biotech firm to use its proprietary platform to advance drug candidates across several therapeutic areas. Insilico will lead the discovery process, while Takeda will have exclusive rights to develop, manufacture and commercialize the drugs. Insilico is set to receive $60 million to kick the project off and is eligible for milestone payments as well as royalties on future sales. And that's a wrap on your TNB Tech Minutes Heads up. We'll be off tomorrow for the holiday, but back on your feed with more tech news Monday morning. Thanks for listening and happy Fourth of July.
[02:29]
C
Hey, this is Telus Demos and I'm Miriam Gottfried. We're reporters at the Wall Street Journal and The hosts of WSJ's take on the Week. It's a weekly show that gives listeners a leg up in the world of markets and investing from the Fed's moves
[02:41]
D
to market bubbles, we dive into the biggest deals, key players and business. Looking for more news and tools that you can use to help navigate the markets? Consider becoming a subscriber to the Wall street journal.
[02:51]
C
Visit subscribe.WSJ.com takeontheweek to subscribe now.